2 results
Approved WMOCompleted
The primary goal is to increase the available information for the surgeon by providing an extensive lymph node map of the patient. The secondary goal is to compare two magnetic detectors for the further development of a laparoscopic version. The…
Approved WMOPending
The objectives of this are to establish the safety, tolerability, and preliminary efficacy of VRDN-001, and the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of VRDN-001 in NHV and TED patients over a dose range of 3.0 to 20.0 mg/kg.